Results 131 to 140 of about 6,306 (210)

Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model. [PDF]

CPT Pharmacometrics Syst Pharmacol
Jakobsson L, Baaz M, Leander J, Gerlee P, Jirstrand M.   +4 more
europepmc   +1 more source

Correction to “Sex‐Related Differences in Physiologically‐Based Biopharmaceutics Modeling”

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
wiley   +1 more source

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework. [PDF]

CPT Pharmacometrics Syst Pharmacol
Pellowe M, Dubbelboer I, Sjögren E.
europepmc   +1 more source

Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer. [PDF]

CPT Pharmacometrics Syst Pharmacol
Yuan D, Bishop CJ, Mehta J, Zhou W, Zhang L, Zhou J, Venkatasubramanian R, Yu A, Agrawal T, Shah S, Baig M, Bauml JM, Kambuj P, Ojeda LC, Clemens PL, Haddish-Berhane N, Su Y, Samtani M.   +17 more
europepmc   +1 more source

PK and PK/PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With Microdosing. [PDF]

CPT Pharmacometrics Syst Pharmacol
Burlot C, Riglet F, Romagnoli M, Leconte A, Delmas A, Schmitt A, Fouliard S.   +6 more
europepmc   +1 more source

Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Zhang S, Yang N, Yang R, Qin Y, Wu T, Wu C, Xie Y, Liu J, Liu C, Pei Q.   +9 more
europepmc   +1 more source

Quantitative Evaluation of Model-Informed Drug Development Implementation in China's Approved Innovative Drugs: From Policy to Practice (2018-2024). [PDF]

CPT Pharmacometrics Syst Pharmacol
Li J, Wang Z, Wei C, He R, Yao Q.
europepmc   +1 more source

Evaluating Preclinical-to-Human Bioavailability Classification Using Smooth ROC Curve Estimation. [PDF]

CPT Pharmacometrics Syst Pharmacol
Erdoğan MS.
europepmc   +1 more source

Future of Pharmacometrics

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018
openaire   +2 more sources

MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications. [PDF]

CPT Pharmacometrics Syst Pharmacol
Javidi M, Alexander GE, Kosoglou T, Vermeulen A, Beutler A, Shagroni T, Valiathan C.   +6 more
europepmc   +1 more source